{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:33:14Z","timestamp":1794105194739,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.7759\/cureus.108798","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:35:50Z","timestamp":1778693750000},"source":"Crossref","is-referenced-by-count":1,"title":["Opioid-Induced Nausea and Vomiting in Patients With Cancer: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Daniela M","family":"Perilla Orozco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto D","family":"Pantoja Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P","family":"Valencia Quivano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E","family":"Cabrera Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N","family":"Ricaurte Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A","family":"S\u00e1nchez-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/26323524241257701","article-title":"Novel therapies for nausea and vomiting in advanced illness and supportive cancer care","volume":"18","author":"Davis MP","year":"2024","unstructured":"Davis MP. Novel therapies for nausea and vomiting in advanced illness and supportive cancer care. Palliat Care Soc Pract. 2024, 18:10.1177\/26323524241257701","journal-title":"Palliat Care Soc Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00470","article-title":"Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue","volume":"38","author":"Henson LA","year":"2020","unstructured":"Henson LA, Maddocks M, Evans C, Davidson M, Hicks S, Higginson IJ. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue. J Clin Oncol. 2020, 38:905-14. 10.1200\/JCO.19.00470","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-00813-0","article-title":"The management of nausea and vomiting not related to anticancer therapy in patients with cancer","volume":"22","author":"Hardy J","year":"2021","unstructured":"Hardy J, Davis MP. The management of nausea and vomiting not related to anticancer therapy in patients with cancer. Curr Treat Options Oncol. 2021, 22:17. 10.1007\/s11864-020-00813-0","journal-title":"Curr Treat Options Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2020.11.5.4","article-title":"Nausea and vomiting not related to cancer therapy: intractable problem or clinical challenge?","volume":"11","author":"Wickham RJ","year":"2020","unstructured":"Wickham RJ. Nausea and vomiting not related to cancer therapy: intractable problem or clinical challenge?. J Adv Pract Oncol. 2020, 11:476-88. 10.6004\/jadpro.2020.11.5.4","journal-title":"J Adv Pract Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0704-8","article-title":"Nausea and vomiting in advanced cancer","volume":"21","author":"Navari RM","year":"2020","unstructured":"Navari RM. Nausea and vomiting in advanced cancer. Curr Treat Options Oncol. 2020, 21:14. 10.1007\/s11864-020-0704-8","journal-title":"Curr Treat Options Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08628-7","article-title":"Pharmacological treatment of cancer\u00a0pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines","volume":"32","author":"Gaertner J","year":"2024","unstructured":"Gaertner J, Boehlke C, Kreye G, Fusi-Schmidhauser T, Mueller E, Roch C. Pharmacological treatment of cancer\u00a0pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines. Support Care Cancer. 2024, 32:436. 10.1007\/s00520-024-08628-7","journal-title":"Support Care Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013860.pub2","article-title":"Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting","volume":"5","author":"Gottlieb M","year":"2022","unstructured":"Gottlieb M, Carlson JN, Peksa GD. Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting. Cochrane Database Syst Rev. 2022, 5:CD013860. 10.1002\/14651858.CD013860.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2018.0260","article-title":"The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review","volume":"22","author":"Sande TA","year":"2019","unstructured":"Sande TA, Laird BJ, Fallon MT. The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med. 2019, 22:90-7. 10.1089\/jpm.2018.0260","journal-title":"J Palliat Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08462-x","article-title":"2020 ASCO, 2023 NCCN, 2023 MASCC\/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients","volume":"32","author":"Kennedy SK","year":"2024","unstructured":"Kennedy SK, Goodall S, Lee SF, et al.. 2020 ASCO, 2023 NCCN, 2023 MASCC\/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer. 2024, 32:280. 10.1007\/s00520-024-08462-x","journal-title":"Support Care Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000234","article-title":"Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments","volume":"8","author":"Vieira C","year":"2023","unstructured":"Vieira C, Bergantim R, Madureira E, et al.. Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments. Porto Biomed J. 2023, 8:e234. 10.1097\/j.pbj.0000000000000234","journal-title":"Porto Biomed J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100278","article-title":"Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta K","year":"2021","unstructured":"Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021, 26:100278. 10.1016\/j.ctarc.2020.100278","journal-title":"Cancer Treat Res Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.08.010","article-title":"A systematic review of the treatment of nausea and\/or vomiting in cancer unrelated to chemotherapy or radiation","volume":"39","author":"Davis MP","year":"2010","unstructured":"Davis MP, Hallerberg G. A systematic review of the treatment of nausea and\/or vomiting in cancer unrelated to chemotherapy or radiation. J Pain Symptom Manage. 2010, 39:756-67. 10.1016\/j.jpainsymman.2009.08.010","journal-title":"J Pain Symptom Manage"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48212","article-title":"Nursing support for nausea and vomiting in patients with cancer: a scoping review","volume":"15","author":"Kobayashi M","year":"2023","unstructured":"Kobayashi M, Kajiwara K, Morikawa M, et al.. Nursing support for nausea and vomiting in patients with cancer: a scoping review. Cureus. 2023, 15:e48212. 10.7759\/cureus.48212","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2224-5820.2012.07.06","article-title":"An overview of nausea\/vomiting in palliative medicine","volume":"1","author":"Smith HS","year":"2012","unstructured":"Smith HS, Smith JM, Smith AR. An overview of nausea\/vomiting in palliative medicine. Ann Palliat Med. 2012, 1:103-14. 10.3978\/j.issn.2224-5820.2012.07.06","journal-title":"Ann Palliat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-09-23-6957","article-title":"Palliative management of nausea and vomiting in advanced cancer","volume":"53","author":"Gurgenci T","year":"2024","unstructured":"Gurgenci T, Podbury B, O'Leary C, Good P. Palliative management of nausea and vomiting in advanced cancer. Aust J Gen Pract. 2024, 53:S33-6. 10.31128\/AJGP-09-23-6957","journal-title":"Aust J Gen Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1411746","article-title":"Comfort care for patients dying in the hospital","volume":"373","author":"Blinderman CD","year":"2015","unstructured":"Blinderman CD, Billings JA. Comfort care for patients dying in the hospital. N Engl J Med. 2015, 373:2549-61. 10.1056\/NEJMra1411746","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08144-0","article-title":"Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients","volume":"31","author":"Kong L","year":"2023","unstructured":"Kong L, Wang J, Guan S, et al.. Nomogram for predicting opioid-induced nausea and vomiting for cancer pain patients. Support Care Cancer. 2023, 31:663. 10.1007\/s00520-023-08144-0","journal-title":"Support Care Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12432","article-title":"Effect of prophylactic anti-emetics on opioid-induced nausea and vomiting: a retrospective observational cohort study","volume":"35","author":"Tamura T","year":"2021","unstructured":"Tamura T, Kawakado K, Makimoto GO, Nakanishi M, Kuyama S. Effect of prophylactic anti-emetics on opioid-induced nausea and vomiting: a retrospective observational cohort study. In Vivo. 2021, 35:1737-42. 10.21873\/invivo.12432","journal-title":"In Vivo"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09211-4","article-title":"MASCC antiemetic consensus recommendations: resource-limited settings","volume":"33","author":"Bosnjak SM","year":"2025","unstructured":"Bosnjak SM, Zilic A, Radhakrishnan V, et al.. MASCC antiemetic consensus recommendations: resource-limited settings. Support Care Cancer. 2025, 33:181. 10.1007\/s00520-025-09211-4","journal-title":"Support Care Cancer"},{"key":"ref20","article-title":"Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients. (Article in Chinese)","volume":"6","author":"Yu SY","year":"2005","unstructured":"Yu SY, Sun Y, Wu YL, et al.. Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients. (Article in Chinese). Chinese J Oncol. 2005, 6:16117902.","journal-title":"Chinese J Oncol"},{"key":"ref21","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Antiemesis. Version 2.2025. (2025). https.\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1415."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients","volume":"27","author":"Roila F","year":"2016","unstructured":"Roila F, Molassiotis A, Herrstedt J, et al.. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol. 2016, 27:v119-33. 10.1093\/annonc\/mdw270","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1196","article-title":"Management of intractable nausea and vomiting in patients at the end of life: \"I was feeling nauseous all of the time . . . nothing was working\"","volume":"298","author":"Wood GJ","year":"2007","unstructured":"Wood GJ, Shega JW, Lynch B, Von Roenn JH. Management of intractable nausea and vomiting in patients at the end of life: \"I was feeling nauseous all of the time . . . nothing was working\". JAMA. 2007, 298:1196-207. 10.1001\/jama.298.10.1196","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173925","article-title":"Preventing opioid-induced nausea and vomiting: rest your head and close your eyes?","volume":"12","author":"Heuser F","year":"2017","unstructured":"Heuser F, Schulz C, Sa\u011flam M, et al.. Preventing opioid-induced nausea and vomiting: rest your head and close your eyes?. PLoS One. 2017, 12:e0173925. 10.1371\/journal.pone.0173925","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13102746","article-title":"Safe management of adverse effects associated with prescription opioids in the palliative care population: a narrative review","volume":"13","author":"Zimmerman A","year":"2024","unstructured":"Zimmerman A, Laitman A. Safe management of adverse effects associated with prescription opioids in the palliative care population: a narrative review. J Clin Med. 2024, 13:2746. 10.3390\/jcm13102746","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75961-2","article-title":"Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study","volume":"10","author":"Besic N","year":"2020","unstructured":"Besic N, Smrekar J, Strazisar B. Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study. Sci Rep. 2020, 10:18766. 10.1038\/s41598-020-75961-2","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S28829","article-title":"Patient considerations in the use of tapentadol for moderate to severe pain","volume":"5","author":"Vadivelu N","year":"2013","unstructured":"Vadivelu N, Huang Y, Mirante B, Jacoby M, Braveman FR, Hines RL, Sinatra R. Patient considerations in the use of tapentadol for moderate to severe pain. Drug Healthc Patient Saf. 2013, 5:151-9. 10.2147\/DHPS.S28829","journal-title":"Drug Healthc Patient Saf"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(91)90041-2","article-title":"The incidence of narcotic-induced emesis","volume":"7","author":"Campora E","year":"1991","unstructured":"Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, Rosso R. The incidence of narcotic-induced emesis. J Pain Symptom Manage. 1991, 7:428-30. 10.1016\/0885-3924(91)90041-2","journal-title":"J Pain Symptom Manage"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011108.pub3","article-title":"Hydromorphone for cancer pain","volume":"8","author":"Li Y","year":"2021","unstructured":"Li Y, Ma J, Lu G, et al.. Hydromorphone for cancer pain. Cochrane Database Syst Rev. 2021, 8:CD011108. 10.1002\/14651858.CD011108.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003341","article-title":"The adverse events of oxycodone in cancer-related pain: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Ma H","year":"2016","unstructured":"Ma H, Liu Y, Huang L, et al.. The adverse events of oxycodone in cancer-related pain: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016, 95:e3341. 10.1097\/MD.0000000000003341","journal-title":"Medicine (Baltimore)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10330-004-0286-0","article-title":"Double-blinded, controlled, randomized study of dihydrocodeine tartrate vs codeine phosphate in treating cancer pain","volume":"4","author":"Wang J","year":"2005","unstructured":"Wang J, Zou J, Gao Y, et al.. Double-blinded, controlled, randomized study of dihydrocodeine tartrate vs codeine phosphate in treating cancer pain. Chinese-German J Clin Oncol. 2005, 4:108-11. 10.1007\/s10330-004-0286-0","journal-title":"Chinese-German J Clin Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2006.0117","article-title":"Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial","volume":"10","author":"Rodriguez RF","year":"2007","unstructured":"Rodriguez RF, Bravo LE, Castro F, et al.. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. J Palliat Med. 2007, 10:56-60. 10.1089\/jpm.2006.0117","journal-title":"J Palliat Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2023.06.022","article-title":"Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain?","volume":"66","author":"Chwistek M","year":"2023","unstructured":"Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain?. J Pain Symptom Manage. 2023, 66:e638-43. 10.1016\/j.jpainsymman.2023.06.022","journal-title":"J Pain Symptom Manage"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00913","article-title":"A history of drug discovery for treatment of nausea and vomiting and the implications for future research","volume":"9","author":"Sanger GJ","year":"2018","unstructured":"Sanger GJ, Andrews PL. A history of drug discovery for treatment of nausea and vomiting and the implications for future research. Front Pharmacol. 2018, 9:913. 10.3389\/fphar.2018.00913","journal-title":"Front Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012002.pub2","article-title":"Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery)","volume":"7","author":"Vayne-Bossert P","year":"2017","unstructured":"Vayne-Bossert P, Haywood A, Good P, Khan S, Rickett K, Hardy JR. Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). Cochrane Database Syst Rev. 2017, 7:CD012002. 10.1002\/14651858.CD012002.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84070","article-title":"Expert consensus guidance on the management of chemotherapy-induced nausea and vomiting: an Indian perspective","volume":"17","author":"Dhabhar B","year":"2025","unstructured":"Dhabhar B, Mahapatra PN, Krishna VM, et al.. Expert consensus guidance on the management of chemotherapy-induced nausea and vomiting: an Indian perspective. Cureus. 2025, 17:e84070. 10.7759\/cureus.84070","journal-title":"Cureus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515442","article-title":"Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting","volume":"374","author":"Navari RM","year":"2016","unstructured":"Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016, 374:1356-67. 10.1056\/NEJMra1515442","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2479417","article-title":"Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates","volume":"21","author":"Park YH","year":"2025","unstructured":"Park YH, Bianchini G, Cort\u00e9s J, et al.. Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates. Future Oncol. 2025, 21:1261-72. 10.1080\/14796694.2025.2479417","journal-title":"Future Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2024-005152","article-title":"Ambulatory palliative care and cancer symptom control: a systematic review and meta-analysis","volume":"15","author":"Shah R","year":"2025","unstructured":"Shah R, Everitt R, Hince D, Kissane D, Michael N. Ambulatory palliative care and cancer symptom control: a systematic review and meta-analysis. BMJ Support Palliat Care. 2025, 15:411-22. 10.1136\/spcare-2024-005152","journal-title":"BMJ Support Palliat Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.12.008","article-title":"Scopolamine for cancer-related nausea and vomiting","volume":"40","author":"LeGrand SB","year":"2010","unstructured":"LeGrand SB, Walsh D. Scopolamine for cancer-related nausea and vomiting. J Pain Symptom Manage. 2010, 40:136-41. 10.1016\/j.jpainsymman.2009.12.008","journal-title":"J Pain Symptom Manage"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1135899","article-title":"The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting","volume":"15","author":"Navari RM","year":"2016","unstructured":"Navari RM. The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting. Expert Opin Drug Saf. 2016, 15:343-56. 10.1517\/14740338.2016.1135899","journal-title":"Expert Opin Drug Saf"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104444","article-title":"Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: the road to success","volume":"201","author":"Belluomini L","year":"2024","unstructured":"Belluomini L, Avancini A, Sposito M, et al.. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: the road to success. Crit Rev Oncol Hematol. 2024, 201:104444. 10.1016\/j.critrevonc.2024.104444","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092131","article-title":"Aromatherapy in palliative care: a single-institute retrospective analysis evaluating the effect of lemon oil pads against nausea and vomiting in advanced cancer patients","volume":"14","author":"Kreye G","year":"2022","unstructured":"Kreye G, Wasl M, Dietz A, Klaffel D, Groselji-Strele A, Eberhard K, Glechner A. Aromatherapy in palliative care: a single-institute retrospective analysis evaluating the effect of lemon oil pads against nausea and vomiting in advanced cancer patients. Cancers (Basel). 2022, 14:2131. 10.3390\/cancers14092131","journal-title":"Cancers (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.10.019","article-title":"Practice patterns of medications for patients with malignant bowel obstruction using a nationwide claims database and the association between treatment outcomes and concomitant use of H2-blockers\/proton pump inhibitors and corticosteroids with octreotide","volume":"55","author":"Minoura T","year":"2018","unstructured":"Minoura T, Takeuchi M, Morita T, Kawakami K. Practice patterns of medications for patients with malignant bowel obstruction using a nationwide claims database and the association between treatment outcomes and concomitant use of H2-blockers\/proton pump inhibitors and corticosteroids with octreotide. J Pain Symptom Manage. 2018, 55:413-9.e2. 10.1016\/j.jpainsymman.2017.10.019","journal-title":"J Pain Symptom Manage"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102512","article-title":"Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: a systematic review and network meta-analysis","volume":"115","author":"Filetti M","year":"2023","unstructured":"Filetti M, Lombardi P, Giusti R, et al.. Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: a systematic review and network meta-analysis. Cancer Treat Rev. 2023, 115:102512. 10.1016\/j.ctrv.2023.102512","journal-title":"Cancer Treat Rev"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2007.52.6.S59","article-title":"The reliability and validity of the Rhodes index of nausea, vomiting and retching in postoperative nausea and vomiting","volume":"6","author":"Kim TH","year":"2007","unstructured":"Kim TH, Choi BM, Hyun-Chin J, Lee MS, Kim DH, Noh GJ. The reliability and validity of the Rhodes index of nausea, vomiting and retching in postoperative nausea and vomiting. Korean J Anesthesiol. 2007, 6:S59-65. 10.4097\/kjae.2007.52.6.S59","journal-title":"Korean J Anesthesiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.33371\/ijoc.v19i2.1289","article-title":"Key predictors for reducing chemotherapy-induced nausea and vomiting among cancer patients","volume":"19","author":"Winahyu-Sari IW","year":"2025","unstructured":"Winahyu-Sari IW, Kartika-Rukmi D, Yulaikhah L. Key predictors for reducing chemotherapy-induced nausea and vomiting among cancer patients. Indones J Cancer. 2025, 19:226-33. 10.33371\/ijoc.v19i2.1289","journal-title":"Indones J Cancer"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5737\/23688076282132138","article-title":"Effectiveness of acupressure on the experience of nausea and vomiting among patients receiving chemotherapy","volume":"28","author":"Byju A","year":"2018","unstructured":"Byju A, Pavithran S, Antony R. Effectiveness of acupressure on the experience of nausea and vomiting among patients receiving chemotherapy. Can Oncol Nurs J. 2018, 28:132-8. 10.5737\/23688076282132138","journal-title":"Can Oncol Nurs J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.62347\/FZAJ6796","article-title":"Factors affecting chemotherapy-induced nausea and vomiting in patients with lung squamous cell carcinoma","volume":"17","author":"Wang J","year":"2025","unstructured":"Wang J. Factors affecting chemotherapy-induced nausea and vomiting in patients with lung squamous cell carcinoma. Am J Transl Res. 2025, 17:5129-40. 10.62347\/FZAJ6796","journal-title":"Am J Transl Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1396637","article-title":"Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy","volume":"14","author":"Bai L","year":"2024","unstructured":"Bai L, Ni L, Lu J, Zhang YY, Yin Y, Zhang W, Duan X. Relationship between nausea and vomiting and physical activity in patients with lung cancer undergoing first chemotherapy. Front Oncol. 2024, 14:1396637. 10.3389\/fonc.2024.1396637","journal-title":"Front Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09319-7","article-title":"Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes","volume":"33","author":"Albanell-Fern\u00e1ndez M","year":"2025","unstructured":"Albanell-Fern\u00e1ndez M, Rodr\u00edguez Mues MC, Figueras C, et al.. Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes. Support Care Cancer. 2025, 33:261. 10.1007\/s00520-025-09319-7","journal-title":"Support Care Cancer"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.59931\/rcp.23.030","article-title":"Explore chemotherapy-induced nausea and vomiting prophylaxis patterns and patient-reported events to suggest improvements in patient care in oncology-specialized hospitals in Vietnam","volume":"1","author":"Nguyen HTH","year":"2023","unstructured":"Nguyen HTH, Duong LK, Vu TD, et al.. Explore chemotherapy-induced nausea and vomiting prophylaxis patterns and patient-reported events to suggest improvements in patient care in oncology-specialized hospitals in Vietnam. R Clin Pharm. 2023, 1:115-26. 10.59931\/rcp.23.030","journal-title":"R Clin Pharm"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.medipa.2013.02.001","article-title":"The Spanish version of the ESAS: a reference tool for evaluating the symptoms of the patient with advanced cancer","volume":"20","author":"Carvajal-Valc\u00e1rcel A","year":"2013","unstructured":"Carvajal-Valc\u00e1rcel A, Mart\u00ednez-Garc\u00eda M, Centeno-Cort\u00e9s C. The Spanish version of the ESAS: a reference tool for evaluating the symptoms of the patient with advanced cancer. Med Paliat. 2013, 20:143-9. 10.1016\/j.medipa.2013.02.001","journal-title":"Med Paliat"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5962","article-title":"Acupuncture for the prevention of chemotherapy-induced nausea and vomiting in cancer patients: a systematic review and meta-analysis","volume":"12","author":"Yan Y","year":"2023","unstructured":"Yan Y, L\u00f3pez-Alcalde J, Zhang L, Siebenh\u00fcner AR, Witt CM, Barth J. Acupuncture for the prevention of chemotherapy-induced nausea and vomiting in cancer patients: a systematic review and meta-analysis. Cancer Med. 2023, 12:12504-17. 10.1002\/cam4.5962","journal-title":"Cancer Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.35509\/01239015.1116","article-title":"Approach to opioid-induced constipation in cancer patients: a narrative review. (Article in Spanish)","volume":"3","author":"S\u00e1nchez-Duque JA","year":"2025","unstructured":"S\u00e1nchez-Duque JA, Manrique-Hern\u00e1ndez E, Pantoja-Molina AD, Morales-Ceballos LX, Manrique-Hern\u00e1ndez KT, Acosta-Quevedo EA. Approach to opioid-induced constipation in cancer patients: a narrative review. (Article in Spanish). Rev Col Cancerol. 2025, 3:89-102. 10.35509\/01239015.1116","journal-title":"Rev Col Cancerol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1310455","article-title":"The preventive effects of ondansetron on chemotherapy-induced nausea and vomiting in adult cancer patients: systematic review from ClinicalTrials.gov","volume":"14","author":"Ashour AM","year":"2023","unstructured":"Ashour AM. The preventive effects of ondansetron on chemotherapy-induced nausea and vomiting in adult cancer patients: systematic review from ClinicalTrials.gov. Front Pharmacol. 2023, 14:1310455. 10.3389\/fphar.2023.1310455","journal-title":"Front Pharmacol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0140","article-title":"Effectiveness of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: a systematic review and network meta-analysis","volume":"24","author":"Yokoe T","year":"2019","unstructured":"Yokoe T, Hayashida T, Nagayama A, et al.. Effectiveness of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: a systematic review and network meta-analysis. Oncologist. 2019, 24:e347-57. 10.1634\/theoncologist.2018-0140","journal-title":"Oncologist"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.05.017","article-title":"Mirtazapine in cancer-associated anorexia and cachexia: a double-blind placebo-controlled randomized trial","volume":"62","author":"Hunter CN","year":"2021","unstructured":"Hunter CN, Abdel-Aal HH, Elsherief WA, Farag DE, Riad NM, Alsirafy SA. Mirtazapine in cancer-associated anorexia and cachexia: a double-blind placebo-controlled randomized trial. J Pain Symptom Manage. 2021, 62:1207-15. 10.1016\/j.jpainsymman.2021.05.017","journal-title":"J Pain Symptom Manage"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2007.01778.x","article-title":"Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression","volume":"62","author":"Kim SW","year":"2008","unstructured":"Kim SW, Shin IS, Kim JM, et al.. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci. 2008, 62:75-83. 10.1111\/j.1440-1819.2007.01778.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012555.pub2","article-title":"Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults","volume":"9","author":"Sutherland A","year":"2018","unstructured":"Sutherland A, Naessens K, Plugge E, Ware L, Head K, Burton MJ, Wee B. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults. Cochrane Database Syst Rev. 2018, 9:CD012555. 10.1002\/14651858.CD012555.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83118","article-title":"Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis","volume":"17","author":"Sarma I","year":"2025","unstructured":"Sarma I, Buragohain S, Lahon J, et al.. Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis. Cureus. 2025, 17:e83118. 10.7759\/cureus.83118","journal-title":"Cureus"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl347","article-title":"Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis","volume":"18","author":"Grunberg SM","year":"2007","unstructured":"Grunberg SM. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol. 2007, 18:233-40. 10.1093\/annonc\/mdl347","journal-title":"Ann Oncol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2025.100938","article-title":"A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapies","volume":"44","author":"Lavanya D","year":"2025","unstructured":"Lavanya D, Prasanna V, Firdous A, Thakur S. A systemic review on chemotherapy induced nausea and vomiting- risk and clinical management with alternative therapies. Cancer Treat Res Commun. 2025, 44:100938. 10.1016\/j.ctarc.2025.100938","journal-title":"Cancer Treat Res Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471254-opioid-induced-nausea-and-vomiting-in-patients-with-cancer-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:35:55Z","timestamp":1778693755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471254-opioid-induced-nausea-and-vomiting-in-patients-with-cancer-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":63,"URL":"https:\/\/doi.org\/10.7759\/cureus.108798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}